US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still have access.

The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.

The approval of Nuvaxovid for use in older and high-risk adults will generate around $175 million in milestone payments from ...